Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jagsonpal Pharmaceuticals Ltd. ( (IN:JAGSNPHARM) ) has shared an announcement.
Jagsonpal Pharmaceuticals Ltd. has announced a scheduled meeting with analysts and institutional investors on November 25, 2025, in Mumbai. This meeting, part of the company’s ongoing investor relations efforts, aims to discuss publicly available information, ensuring transparency and engagement with stakeholders without disclosing any unpublished price-sensitive information.
More about Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is involved in providing a range of healthcare solutions and is positioned within the Indian market.
Average Trading Volume: 9,063
Technical Sentiment Signal: Buy
Current Market Cap: 13.97B INR
For detailed information about JAGSNPHARM stock, go to TipRanks’ Stock Analysis page.